ACE2 inhibits liver fibrosis [19], protecting against the development of diabetic retinopathy [20] and acute lung failure [21], whereas the genetic deletion of this enzyme leads to endothelial dysfunction and redox imbalance in mice [22], as well as hepatic steatosis [18]. Here, ACE2 is linked to fatty liver disease.